200 related articles for article (PubMed ID: 21463567)
1. Preparation, characterization and in vivo assessment of Gd-albumin and Gd-dendrimer conjugates as intravascular contrast-enhancing agents for MRI.
Nwe K; Milenic D; Bryant LH; Regino CA; Brechbiel MW
J Inorg Biochem; 2011 May; 105(5):722-7. PubMed ID: 21463567
[TBL] [Abstract][Full Text] [Related]
2. Comparison of MRI properties between derivatized DTPA and DOTA gadolinium-dendrimer conjugates.
Nwe K; Bernardo M; Regino CA; Williams M; Brechbiel MW
Bioorg Med Chem; 2010 Aug; 18(16):5925-31. PubMed ID: 20663676
[TBL] [Abstract][Full Text] [Related]
3. Gadolinium MRI contrast agents based on triazine dendrimers: relaxivity and in vivo pharmacokinetics.
Lim J; Turkbey B; Bernardo M; Bryant LH; Garzoni M; Pavan GM; Nakajima T; Choyke PL; Simanek EE; Kobayashi H
Bioconjug Chem; 2012 Nov; 23(11):2291-9. PubMed ID: 23035964
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of nanoglobular macrocyclic Mn(II) chelate conjugates as non-gadolinium(III) MRI contrast agents.
Tan M; Ye Z; Jeong EK; Wu X; Parker DL; Lu ZR
Bioconjug Chem; 2011 May; 22(5):931-7. PubMed ID: 21473650
[TBL] [Abstract][Full Text] [Related]
5. Cyclen-based Gd
Rashid HU; Martines MAU; Jorge J; de Moraes PM; Umar MN; Khan K; Rehman HU
Bioorg Med Chem; 2016 Nov; 24(22):5663-5684. PubMed ID: 27729196
[TBL] [Abstract][Full Text] [Related]
6. Gd-complexes of 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-1,4,7,10-tetraacetic acid (DOTA) conjugates of tranexamates as a new class of blood-pool magnetic resonance imaging contrast agents.
Gu S; Kim HK; Lee GH; Kang BS; Chang Y; Kim TJ
J Med Chem; 2011 Jan; 54(1):143-52. PubMed ID: 21141934
[TBL] [Abstract][Full Text] [Related]
7. Poly(amidoamine) dendrimer based MRI contrast agents exhibiting enhanced relaxivities derived via metal preligation techniques.
Nwe K; Bryant LH; Brechbiel MW
Bioconjug Chem; 2010 Jun; 21(6):1014-7. PubMed ID: 20462240
[TBL] [Abstract][Full Text] [Related]
8. Self-assembling DNA quadruplex conjugated to MRI contrast agents.
Cai J; Shapiro EM; Hamilton AD
Bioconjug Chem; 2009 Feb; 20(2):205-8. PubMed ID: 19125646
[TBL] [Abstract][Full Text] [Related]
9. Macromolecular and dendrimer-based magnetic resonance contrast agents.
Bumb A; Brechbiel MW; Choyke P
Acta Radiol; 2010 Sep; 51(7):751-67. PubMed ID: 20590365
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo comparative performance studies of gadolinium-loaded zeolites and Gd-DOTA as contrast agents for MRI applications.
Contro J; Silva DA; Santisteban OAN; Narayana PA; Nery JG
J Biomed Mater Res B Appl Biomater; 2021 Aug; 109(8):1105-1115. PubMed ID: 33283412
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of novel macrocyclic and acyclic ligands as contrast enhancement agents for magnetic resonance imaging.
Chong HS; Garmestani K; Bryant LH; Milenic DE; Overstreet T; Birch N; Le T; Brady ED; Brechbiel MW
J Med Chem; 2006 Mar; 49(6):2055-62. PubMed ID: 16539394
[TBL] [Abstract][Full Text] [Related]
12. Prediction of q-values and conformations of gadolinium chelates for magnetic resonance imaging.
Castonguay LA; Treasurywala AM; Caulfield TJ; Jaeger EP; Kellar KE
Bioconjug Chem; 1999; 10(6):958-64. PubMed ID: 10563764
[TBL] [Abstract][Full Text] [Related]
13. Improving T₁ and T₂ magnetic resonance imaging contrast agents through the conjugation of an esteramide dendrimer to high-water-coordination Gd(III) hydroxypyridinone complexes.
Klemm PJ; Floyd WC; Smiles DE; Fréchet JM; Raymond KN
Contrast Media Mol Imaging; 2012; 7(1):95-9. PubMed ID: 22344885
[TBL] [Abstract][Full Text] [Related]
14. An intravascular MRI contrast agent based on Gd(DO3A-Lys) for tumor angiography.
Yang CT; Chandrasekharan P; He T; Poh Z; Raju A; Chuang KH; Robins EG
Biomaterials; 2014 Jan; 35(1):327-36. PubMed ID: 24138829
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and Relaxometric Characterization of New Poly[N,N-bis(3-aminopropyl)glycine] (PAPGly) Dendrons Gd-Based Contrast Agents and Their in Vivo Study by Using the Dynamic Contrast-Enhanced MRI Technique at Low Field (1 T).
Granato L; Longo D; Boutry S; Vander Elst L; Henoumont C; Aime S; Muller RN; Laurent S
Chem Biodivers; 2019 Nov; 16(11):e1900322. PubMed ID: 31544357
[TBL] [Abstract][Full Text] [Related]
16. Targeted gadolinium-loaded dendrimer nanoparticles for tumor-specific magnetic resonance contrast enhancement.
Swanson SD; Kukowska-Latallo JF; Patri AK; Chen C; Ge S; Cao Z; Kotlyar A; East AT; Baker JR
Int J Nanomedicine; 2008; 3(2):201-10. PubMed ID: 18686779
[TBL] [Abstract][Full Text] [Related]
17. Physical, chemical and biological evaluations of CMD-A2-Gd-DOTA. A new paramagnetic dextran polymer.
Corot C; Schaefer M; Beauté S; Bourrinet P; Zehaf S; Bénizé V; Sabatou M; Meyer D
Acta Radiol Suppl; 1997; 412():91-9. PubMed ID: 9240087
[TBL] [Abstract][Full Text] [Related]
18. GdIII complexes with fast water exchange and high thermodynamic stability: potential building blocks for high-relaxivity MRI contrast agents.
Laus S; Ruloff R; Tóth E; Merbach AE
Chemistry; 2003 Aug; 9(15):3555-66. PubMed ID: 12898682
[TBL] [Abstract][Full Text] [Related]
19. How to compare the efficiency of albumin-bound and nonalbumin-bound contrast agents in vivo: the concept of dynamic relaxivity.
Port M; Corot C; Violas X; Robert P; Raynal I; Gagneur G
Invest Radiol; 2005 Sep; 40(9):565-73. PubMed ID: 16118549
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
